Search research articles
Contact Us
Filters
Showing results (301-310 of 606) with videos related to
Page
of 61
Sort By:
Molecular Plant-Microbe Interactions : MPMI
|
November 17, 2017
daTALbase: A Database for Genomic and Transcriptomic Data Related to TAL Effectors
Alvaro L Pérez-Quintero, Léo Lamy, Carlos A Zarate, et al.
Physiological Genomics
|
May 15, 2014
Transcriptomics of the fetal hypothalamic response to brachiocephalic occlusion and estradiol treatment
Charles E Wood, Maria Belen Rabaglino, Elaine Richards, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 28, 1998
Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico
K S Elenitoba-Johnson, A Zarate-Osorno, A Meneses, et al.
Expert Review of Clinical Pharmacology
|
October 27, 2016
Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression
Ioline D Henter, Rafael T de Sousa, Philip W Gold, et al.
Journal of Affective Disorders
|
December 4, 2019
Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression
Elia E Acevedo-Diaz, Grace W Cavanaugh, Dede Greenstein, et al.
Bipolar Disorders
|
September 12, 2007
Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, et al.
American Journal of Medical Genetics. Part A
|
April 28, 2015
Phenotypic modifications of patients with full chromosome aneuploidies and concurrent suspected or confirmed second diagnoses
Yuri A Zarate, Katherine A Bosanko, Elizabeth Bhoj, et al.
The International Journal of Neuropsychopharmacology
|
September 17, 2021
Evaluation of the Safety, Tolerability, and Pharmacokinetic Profiles of TP0473292 (TS-161), A Prodrug of a Novel Orthosteric mGlu2/3 Receptor Antagonist TP0178894, in Healthy Subjects and Its Antidepressant-Like Effects in Rodents
Mai Watanabe, Brian Marcy, Ayano Hiroki, et al.
The American Journal of Psychiatry
|
August 16, 2016
Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD Study
Rodrigo Machado-Vieira, David A Luckenbaugh, Elizabeth D Ballard, et al.
The International Journal of Neuropsychopharmacology
|
September 6, 2018
Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder
Lawrence Park, Maura Furey, Allison C Nugent, et al.
Page
of 61
Search research articles
Search
Showing results (301-310 of 606) with videos related to
Sort By:
Page
of 61
Molecular Plant-Microbe Interactions : MPMI
|
November 17, 2017
daTALbase: A Database for Genomic and Transcriptomic Data Related to TAL Effectors
Alvaro L Pérez-Quintero, Léo Lamy, Carlos A Zarate, et al.
Physiological Genomics
|
May 15, 2014
Transcriptomics of the fetal hypothalamic response to brachiocephalic occlusion and estradiol treatment
Charles E Wood, Maria Belen Rabaglino, Elaine Richards, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 28, 1998
Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico
K S Elenitoba-Johnson, A Zarate-Osorno, A Meneses, et al.
Expert Review of Clinical Pharmacology
|
October 27, 2016
Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression
Ioline D Henter, Rafael T de Sousa, Philip W Gold, et al.
Journal of Affective Disorders
|
December 4, 2019
Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression
Elia E Acevedo-Diaz, Grace W Cavanaugh, Dede Greenstein, et al.
Bipolar Disorders
|
September 12, 2007
Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, et al.
American Journal of Medical Genetics. Part A
|
April 28, 2015
Phenotypic modifications of patients with full chromosome aneuploidies and concurrent suspected or confirmed second diagnoses
Yuri A Zarate, Katherine A Bosanko, Elizabeth Bhoj, et al.
The International Journal of Neuropsychopharmacology
|
September 17, 2021
Evaluation of the Safety, Tolerability, and Pharmacokinetic Profiles of TP0473292 (TS-161), A Prodrug of a Novel Orthosteric mGlu2/3 Receptor Antagonist TP0178894, in Healthy Subjects and Its Antidepressant-Like Effects in Rodents
Mai Watanabe, Brian Marcy, Ayano Hiroki, et al.
The American Journal of Psychiatry
|
August 16, 2016
Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD Study
Rodrigo Machado-Vieira, David A Luckenbaugh, Elizabeth D Ballard, et al.
The International Journal of Neuropsychopharmacology
|
September 6, 2018
Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder
Lawrence Park, Maura Furey, Allison C Nugent, et al.
Page
of 61